Treadstone Associates
Case File · Financial Due Diligence

A take-or-pay commitment carried as if it were free

Anonymised, illustrative composite. A packaging distributor's supply agreement guaranteed a minimum annual purchase whether or not the business needed it. The company had never once used the full amount, and the shortfall it paid for was invisible on the balance sheet.

Treadstone Associates · Updated 2026

At a glance

  • • Ontario, share purchase of a packaging distributor with a five-year take-or-pay supply agreement, four years remaining.
  • • The contract obliged the company to purchase $1,400,000 of product a year, or pay the difference in cash for whatever it did not take.
  • • The company's actual usage had never exceeded roughly $850,000 a year — a guaranteed shortfall payment of about $550,000 a year for four more years.
  • • The obligation is not a debt in the legal sense: no note, no lender, no default remedy beyond the supply contract itself. But it is fixed, non-cancellable, and independent of the business's own output.
  • • Under ASPE, an unconditional purchase obligation like this is disclosed, if at all, only in the commitments note — it is not recognised as a liability on the balance sheet, which is why it never showed up in the numbers the seller presented.
  • • Treated as a debt-like item and present-valued at the deal's borrowing rate, the four years of guaranteed shortfall payments reduced the equity price by roughly $1,850,000 — a direct, dollar-for-dollar cut, not one run through the EBITDA multiple.

The situation

The target distributed packaging materials and had, three years earlier, signed a five-year supply agreement with its principal vendor to secure pricing and guaranteed capacity during a period of tight supply. The agreement fixed an annual minimum purchase commitment of $1,400,000. If the company took less than that in a year, it still had to pay the vendor the difference in cash — a standard take-or-pay structure.

The buyer was acquiring the company by share purchase, with a conventional cash-free, debt-free pricing structure: an enterprise value set on a multiple of EBITDA, adjusted to an equity price by adding cash and subtracting debt and debt-like items at closing.

The problem

The company's actual demand for the vendor's product had never come close to the $1,400,000 minimum. Usage ran around $850,000 a year, and the shortfall payment — roughly $550,000 annually — had simply been paid each year and booked to cost of goods sold, indistinguishable in the financial statements from ordinary purchases. There was no separate line item, no note calling it out, and no balance sheet liability, because under ASPE an unconditional purchase obligation of this kind is not recognised as a liability until the obligation to pay actually crystallises period by period — it is, at most, a commitment disclosed in the notes, and this target's notes did not disclose it.

Four years remained on the agreement. The buyer's own production plan, which consolidated volume from a second facility being closed, meant the company's usage would stay at roughly the historical $850,000 level, not grow into the commitment. The shortfall payment was not a one-off; it was a predictable, contractually fixed cash outflow for the whole remaining term, regardless of how the business actually performed.

The numbers

Annual minimum purchase commitment $1,400,000; realistic ongoing usage approximately $850,000; guaranteed shortfall payment approximately $550,000 a year, for four remaining years — $2,200,000 undiscounted.

Present-valued at the deal's own borrowing rate of 8%, used consistently elsewhere in the financing for the transaction, the four years of guaranteed shortfall payments came to approximately $1,850,000. Deducted dollar-for-dollar as a debt-like item in the closing adjustment, rather than folded into the EBITDA run-rate and multiplied, it reduced the equity price by that amount directly.

The rule that decided it

No statute or accounting standard dictates how a take-or-pay shortfall must be treated in a purchase price. The question the diligence team had to answer was a classification question, not a legal one: is this an ordinary executory contract — a forward commercial arrangement whose cost simply flows through future operating results and gets captured, if at all, through the multiple — or is it debt in substance, a fixed and non-cancellable payment stream independent of the business's own performance that belongs in the same bucket as a bank loan?

The distinguishing features here were that the shortfall payment is fixed in amount, runs for a defined remaining term, and is owed whether or not the company buys anything at all from anyone else in the meantime — the company is free to source packaging elsewhere and simply pays the vendor regardless. That combination is what puts it on the debt side of the line rather than the ordinary-course-risk side: a normal supply contract's cost varies with how much the business actually needs; this one does not.

The outcome

The parties agreed to treat the present value of the guaranteed shortfall as a debt-like item in the closing statement, reducing the equity price by approximately $1,850,000. The purchase agreement's definition of “Indebtedness” was amended specifically to capture “any fixed, non-cancellable minimum purchase or take-or-pay obligation under a supply or service agreement, valued at the present value of the remaining guaranteed payments,” closing the gap for any similar item diligence had not yet found.

The seller argued, unsuccessfully, that the shortfall was an ordinary operating cost that belonged in the EBITDA run-rate rather than a dollar-for-dollar price reduction. The buyer's position held because the obligation survives regardless of the business's output — the defining trait of a debt-like item — where an ordinary supply cost would simply shrink if the business bought less.

What it would have cost otherwise

If the shortfall had been left inside EBITDA and priced through the multiple, its effect on the purchase price would have been valued at the multiple applied to its annual impact on earnings — a very different number from its actual present value as a fixed obligation, and one that assumes the market will keep paying a multiple for a cash outflow that is not going to shrink. Worse, treating it as an ordinary operating cost rather than a closing adjustment would have left the buyer paying full price today for a liability it will still be paying down four years from now, on top of whatever multiple was applied to the earnings that liability was already suppressing.

The tell

The tell was in the general ledger, not the balance sheet: the shortfall payments were there, buried inside cost of goods sold, but nothing on the balance sheet or in the notes flagged a forward obligation. The only way to find it was to read the supply agreement itself, line by line, and notice that the minimum purchase commitment did not move with the company's own consumption. A liability that only shows up in a contract nobody asked for in the first data room pull is exactly the kind of thing a standard financial-statement review will not surface on its own.

Takeaways

  • • A take-or-pay shortfall payment can sit inside cost of goods sold for years without ever appearing as a liability — ASPE does not require an unconditional purchase obligation to be recognised on the balance sheet.
  • • The classification test is whether the obligation is fixed and non-cancellable independent of the business's own output. If so, it behaves like debt and belongs in the closing adjustment, not the EBITDA multiple.
  • • Present-value the remaining guaranteed payments at the deal's own borrowing rate, and deduct that figure dollar-for-dollar — folding it into the run-rate and multiplying it produces a different, usually smaller, number.
  • • Read supply, logistics and licensing agreements directly for minimum-purchase and take-or-pay language; a standard note-disclosure review of ASPE financial statements will often miss it entirely.
  • • Amend the purchase agreement's definition of debt-like items to capture fixed, non-cancellable minimum-purchase obligations generally, not just the one instance diligence happened to find.

Sources

  • • No statute governs the debt-like classification of a take-or-pay shortfall; it is a purchase-price mechanics and accounting-classification question, resolved by the terms of the supply agreement and the purchase agreement's own definition of indebtedness.
  • • Not recognised on the balance sheet: under Canadian ASPE, an unconditional purchase obligation of this kind is, at most, a note disclosure rather than a recognised liability, which is a fact about private-enterprise accounting practice generally rather than a specific statute or handbook section verified here.
  • • Treadstone Law — purchase price adjustment clauses in an Ontario business sale — background on how a working-capital adjustment moves the closing price. It addresses the working-capital peg specifically, not the separate debt-like-item bucket a take-or-pay commitment falls into, which is the distinction this file turns on.

See where AI pays off first in your business.

A 30-minute call is enough to tell you whether AI pays for itself here.

The Canadian benchmark

What do businesses like this one actually sell for?

Canadian small-business transaction data is not published anywhere, so most valuations in this country quote an American benchmark. The Deavo–Treadstone Acquisition Index is a daily record of Canadian listings built to replace that: asking-price distributions by province and city are published now, and days on market, departure rates and asking-to-sale spreads follow as the series lengthens. Leave an email and we will tell you as each measure lands.

No pitch, no listings. One email when the first report lands.